SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 13, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $6.2M total
Actionable Insight • Neutral

The CEO's large post-earnings sales are notable but not alarming given the modest proportion of market cap and the stock's recent run-up. Monitor for any follow-on sales in the next 30 days; if the CEO continues selling at this pace, it would signal a more bearish view. The strong Q2 results and raised guidance remain the dominant narrative.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$347.48
T+0 close · Aug 13, 2026 · via day close
Latest settled
+20.10%
T+60 · $417.33
Vs SPY
+23.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $347.48entry
  2. T+1 · 3mo ago +4.33%α +4.80% · $362.51
  3. T+5 · 3mo ago +7.77%α +9.14% · $374.47
  4. T+20 · 2mo ago +1.83%α +3.82% · $353.83
  5. T+60 · 8d ago +20.10%α +23.15% · $417.33

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO John Oyler sold $46.3M of stock over two days (Aug 11-12) following a strong Q2 earnings beat that sent shares up ~10%. While the sales are large in absolute terms, they represent only ~0.11% of the $40.8B market cap, falling just above the 0.1% materiality threshold. The cluster is amplified by the proximity to earnings and the CEO's dominant role, but the sales are likely liquidity-driven after a significant run-up rather than a bearish signal on fundamentals, given the raised guidance and strong pipeline momentum.

Key Financial Metrics

Direction
selling
Total Value
$47.3M
Insiders
2

Key Facts

  • CEO John Oyler sold ~$46.3M in open-market sales over Aug 11-12, representing ~0.11% of market cap.
  • SVP/GC Lee Chan Henry exercised non-cash derivatives and sold ~$960K in open-market sales on Aug 11.
  • The cluster follows a strong Q2 2026 earnings report (revenue +30% YoY, raised guidance) that drove the stock up ~10% in the prior week.
  • Total open-market sales in the cluster (~$47.3M) are modest relative to the $40.8B market cap, below the 0.5% threshold for significant insider selling.
  • The CEO's sales are concentrated and large in absolute terms, but the stock is near all-time highs post-earnings, consistent with routine diversification.

Financial Impact

CEO sold ~$46.3M (0.11% of market cap); total cluster open-market sales ~$47.3M

dilutioninsider ownership

Risk Factors

  • CEO selling could be interpreted as a lack of conviction at current levels, especially if the stock pulls back.
  • Further insider sales in coming weeks could compound negative sentiment.
  • The stock's OTC listing may amplify volatility on any negative news.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONC-1786669363708

Track record

27 reports on ONC

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $416.54 +0.00% settles Nov 23
  2. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $416.54 −0.82% settles Nov 18
  3. Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $416.54 −0.19% ▼ −1.45% +0.25% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $416.54 +2.35% ▲ +2.35% −0.24% vs SPY
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $416.54 +7.56% ▲ +7.41% +4.12% vs SPY
  6. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $416.54 +10.26% ▲ +11.17% +12.08% vs SPY
  7. Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $416.54 −15.18% ▲ +3.11% +3.53% vs SPY
  8. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $416.54 +13.17% ▼ −0.76% +0.42% vs SPY
  9. Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $416.54 +20.21% ▲ +1.25% +1.47% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $416.54 +16.27% ▼ −1.24% −0.03% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026